Please ensure Javascript is enabled for purposes of website accessibility
Contáctenos Contáctenos
ES
Inicio > Productos Destacados > Oncology Research > Melanoma

960 resultados de producto para "Melanoma"

Opciones+
Opciones
Confirmar
  • Tipos de productos
    0 seleccionado
    Antibodies (298)
    Stable Cell Lines (1)
    Assay Kit (419)
    Proteins (75)
    Biosimilars (1)
    Research Biosimilar (157)
  • Sistema de expresión
    0 seleccionado
    Mammalian Cells (186)
    HEK293T (1)
    E. coli (35)
  • Objetivo
    0 seleccionado
    Ixekizumab (1)
    Siltuximab (3)
    Suvizumab (1)
    CD47/MER6 & PDCD1 / PD-1 & CD137/4-1BB/TNFRSF9 (1)
    Ibritumomab (1)
    RBD (Omicron/BA.4/BA.5) (1)
    CD278/ICOS (1)
    Itolizumab (1)
    TPP15 (1)
    Anetumab (1)
    Zanolimumab (1)
    Blosozumab (1)
    Lacnotuzumab (1)
    Iscalimab (1)
    Olaratumab (1)
    Glycoprotein (5)
    PMEL17/ME20M (9)
    Protein A (1)
    Tisotumab (1)
    RBD (Kappa) (1)
    Ramucirumab (1)
    Nesvacumab (1)
    Pembrolizumab (3)
    mitF/aspF1 (1)
    Milatuzumab (1)
    Avelumab (3)
    Befovacimab (1)
    Casirivimab (1)
    Bimagrumab (1)
    gC/Envelope glycoprotein C (1)
    Utomilumab (1)
    Gevokizumab (1)
    Tezepelumab (1)
    Teprotumumab (1)
    IL6 (1)
    Bevacizumab (3)
    SARS-CoV-2 Neutralization Antibody (3)
    Ivuxolimab (1)
    PDL1 & VEGF (1)
    Panitumumab (3)
    Ieramilimab (1)
    CD274/PD-L1 & VEGFA (1)
    TYRP1 (3)
    CD19 & PD-L1 & CD3E & CD137 (1)
    S100A9 (4)
    Asp f 1/mitF (1)
    CD274/PD-L1 & CD134/OX40 (1)
    CD274/PD-L1 & CD28 & CD152/CTLA4 (1)
    CD47/MER6 & CD274/PD-L1 (2)
    S100A16 (1)
    HLA-A2-peptide (TDQVPFSV) Complex (1)
    Pogalizumab (1)
    Serclutamab (1)
    Remtolumab (1)
    Clazakizumab (1)
    Mosunetuzumab (1)
    TPP17 (1)
    Conatumumab (1)
    Romosozumab (1)
    TYR (1)
    Romiplostim (2)
    Tovetumab (1)
    M/Matrix protein (2)
    CD3E (1)
    Belantamab (1)
    PD-L1 / VEGF-A (1)
    Certolizumab (2)
    Enoblituzumab (1)
    Cabiralizumab (1)
    Gremubamab (1)
    Human β Amyloid (1-42) (1)
    RBD (Delta Plus) (1)
    Spike glycoprotein (RBD) (1)
    Vanucizumab (1)
    Sintilimab (1)
    Glycoprotein G (2)
    Durvalumab (3)
    CD80&IL2 (1)
    Concizumab (1)
    Imdevimab (1)
    CD117/KIT (24)
    Rolinsatamab (1)
    gC/UL44 (1)
    Magrolimab (1)
    CD20/MS4A1 (3)
    Etanercept (3)
    Brolucizumab (1)
    RBD (Omicron/BA.5) (3)
    HLA-A2-peptide (ITDQVPFSV) Complex (4)
    EGFR & CD3E & PD-L1 & 4-1BB (1)
    CD366/TIM-3 & CD274/PD-L1 (1)
    TRP-1 & CD47/MER6 (1)
    CD274/PD-L1 & CD279/PD-1 (1)
    Oleclumab (1)
    IDO1 (2)
    CD366/TIM-3 & CD279/PD-1 (2)
    Sarilumab (2)
    CD152/CTLA4 & CD279/PD-1 (1)
    Ranibizumab (3)
    NP/Nucleoprotein (3)
    Tavolimab (1)
    Secukinumab (2)
    Imlifidase (5)
    Olokizumab (1)
    Foravirumab (1)
    CD47/MER6 & CD274/PD-L1/B7-H1 (2)
    Ocaratuzumab (1)
    Elotuzumab (1)
    Cusatuzumab (1)
    TPP47 (1)
    Drozitumab (1)
    Ontamalimab (1)
    Eldelumab (1)
    Sacituzumab (1)
    Eculizumab (3)
    Varlilumab (1)
    Tirzepatide (2)
    gp100 peptide-HLA Complex (1)
    Teclistamab (1)
    Mirzotamab (1)
    CD223 (1)
    Emactuzumab (1)
    M1R (5)
    Human β Amyloid (1-40) (1)
    Imalumab (1)
    Semaglutide (2)
    Ascrinvacumab (1)
    TFF3 (1)
    Tislelizumab (1)
    Disitamab (1)
    Pacmilimab (1)
    TDP2 (1)
    Marstacimab (1)
    Daratumumab (3)
    gD/US6 (1)
    Basiliximab (1)
    Elezanumab (1)
    Apamistamab (1)
    HLA-A2-peptide (YLEPGPVT) Complex (4)
    Calprotectin (S100A8/9) (3)
    BRAF/B-Raf (5)
    Mavezelimab (1)
    CD137/4-1BB & CD274/PD-L1 (3)
    TRP-1 & CD134/OX40 (1)
    CD274/PD-L1 & TGFBR2/TGFR-2 (1)
    CD80/B7-1 & CD86/B7-2 (2)
    S100A11 (2)
    RBD (6)
    Varisacumab (1)
    RBD (Omicron/JN.1) (1)
    Lirilumab (1)
    CTLA4 & PD1 (2)
    Tesidolumab (1)
    Sirukumab (1)
    Rafivirumab (1)
    cAMP (1)
    RBD (WT) (1)
    Vorsetuzumab (1)
    G/Major surface glycoprotein G (1)
    Lexatumumab (1)
    Mirikizumab (2)
    PDL1 (6)
    Aflibercept (1)
    Ipilimumab (2)
    GP/Envelope glycoprotein (4)
    T3E (1)
    Golimumab (3)
    Omburtamab (1)
    TAU pT181 (1)
    Evolocumab (1)
    EPO/Erythropoietin (1)
    Lupartumab (1)
    Toripalimab (1)
    Exenatide acetate (2)
    Pertuzumab (3)
    CD137/4-1BB/TNFRSF9& CD274/PD-L1/B7-H1 (1)
    Denosumab (3)
    US8/gE (1)
    Sibrotuzumab (1)
    Fluorescein & CD274/PD-L1 (1)
    Camidanlumab (1)
    Mazdutide (2)
    HLA-A2-peptide (KTWGQYWQV) Complex (2)
    Favezelimab (1)
    CD86/B7-2 (26)
    CD152/CTLA4 & CD274/PD-L1 (1)
    Zampilimab (1)
    NRAS (2)
    CD175/Tn (10)
    S100A6 (1)
    Omalizumab (2)
    LAG3 & PD-1 (1)
    Daclizumab (1)
    Enfortumab (1)
    Emibetuzumab (1)
    RBD (Delta) (3)
    FLT1/VEGFR1 & CD274/PD-L1 (1)
    RBD (Omicron/KP.2) (1)
    Tibulizumab (1)
    Ziltivekimab (1)
    VASH2/Vasohibin-2 (1)
    Carlumab (1)
    RBD (Alpha) (1)
    N/Nucleoprotein (1)
    Tigatuzumab (1)
    Glembatumumab (1)
    Lenzilumab (1)
    Semorinemab (1)
    Talacotuzumab (1)
    S100A5 (4)
    Tremelimumab (1)
    gG/US4 (2)
    T-cell surface antigen T3/Leu-4 epsilon chain (1)
    Pasotuxizumab (1)
    TIGIT & CD274/PD-L1 (1)
    Cixutumumab (1)
    H3L (3)
    TAU pT217 (1)
    Andecaliximab (1)
    Alirocumab (1)
    Cinpanemab (1)
    CD274/PD-L1 & CD28 (1)
    TYR/Tyrosinase (2)
    Trastuzumab (2)
    Nirsevimab (1)
    CD47/MER6 & PDCD1 / PD-1 / CD279 (1)
    Obinutuzumab (2)
    Cetuximab (3)
    Ifabotuzumab (1)
    CD366/HAVCR2/TIM-3 (4)
    Spike glycoprotein E2 (2)
    Simlukafusp Alfa (1)
    CD152/CTLA4 & CD134/OX40 (1)
    Rituximab (1)
    CD274/PD-L1 & CD137/TNFRSF9 (1)
    S100A12 (1)
    S100A14 (1)
    CD274/PD-L1 (81)
    Anifrolumab (1)
    S100a15a (1)
    Spike glycoprotein E1 (2)
    Spike glycoprotein (10)
    Crizanlizumab (1)
    CD340/ERBB2 (1)
    Codrituzumab (1)
    Tanezumab (1)
    Vunakizumab (1)
    Tosatoxumab (1)
    SOX10 (3)
    RBD (Beta) (1)
    Meplazumab (1)
    Balstilimab (1)
    Namilumab (1)
    Dilpacimab (1)
    Tilavonemab (1)
    Natalizumab (2)
    S100A8 (3)
    Vibecotamab (1)
    Zalifrelimab (1)
    gB/Envelope glycoprotein B (1)
    T-cell surface glycoprotein CD3 epsilon chain (1)
    Rosopatamab (2)
    Infliximab (2)
    Frovocimab (1)
    Dalotuzumab (1)
    E8L (5)
    S100A2 (1)
    Depatuxizumab (1)
    Retatrutide (1)
    Zanidatamab (1)
    Palivizumab (3)
    KITLG/SCF (1)
    Afutuzumab (1)
    sCD14 (1)
    CD366/TIM-3 (34)
    Abatacept (1)
    S100A13 (1)
    S100A4 (3)
    CD274/PD-L1 & CD152/CTLA4 (1)
    Indatuximab (1)
    S100B (9)
    CD223/LAG3 (41)
    CD279/PD-1 & CD274/PD-L1 (1)
    CD137/4-1BB & CD274/PD-L1 & ROR1 & CD3 (1)
    S100A1 (2)
    Vofatamab (1)
    CD223/LAG3 & CD279/PD-1 (4)
    F/Fusion glycoprotein F0 (5)
    Letolizumab (1)
    dsRNA (1)
    Ibalizumab (1)
    Ianalumab (1)
    Tocilizumab (3)
    Spike Protein (Trimer) (2)
    Dupilumab (3)
    Inclacumab (1)
    IL1RL1/ST2 (1)
    VSIR/VISTA & CD274/PD-L1 (1)
    Cergutuzumab (1)
    cGMP (1)
    Lorvotuzumab (1)
    RBD (Gamma) (1)
    MITF (1)
    Cetrelimab (1)
    DCT (2)
    Otilimab (1)
    Navicixizumab (1)
    VEGFA & B7-H1 / PD-L1 / CD274 (1)
    Zagotenemab (1)
    gE/Envelope glycoprotein E (1)
    Tarextumab (1)
    Lodelcizumab (1)
    PD-L1 & VEGF (1)
    Figitumumab (1)
    A35R (5)
    Farletuzumab (1)
    Ustekinumab (3)
    CD79B (2)
    Losatuxizumab (1)
    Afasevikumab (1)
    β-D-Glucan (1)
    Suptavumab (1)
    B7-H1 / PD-L1 / CD274 & CD3E (1)
    Epcoritamab (1)
    Icrucumab (1)
    CD152/CTLA4 (86)
    CD274/PD-L1 & TGFBR2 (1)
    CD279/PD-1 & CD152/CTLA4 (4)
    CD274/PD-L1 & CD3E (1)
    p-Tyr (1)
    Glofitamab (1)
    Guselkumab (3)
    ATP7B (1)
    Benufutamab (1)
    Amatuximab (1)
    Tregalizumab (1)
    PD-L1 & TGF-Beta (1)
    NP/Nucleocapsid (5)
    dsDNA (1)
    Astegolimab (1)
    Adalimumab (3)
    Tiragolumab (2)
    Labetuzumab (1)
    Obiltoxaximab (1)
    BSA (1)
    RBD (E484K) (1)
    Alacizumab (1)
    Faricimab (1)
    Nivolumab (3)
    Atezolizumab (3)
    Sotrovimab (1)
    MLANA (4)
    Edrecolomab (1)
    gD/Envelope glycoprotein D (1)
    Urelumab (1)
    Canakinumab (1)
    LAG-3 & PD-1 (1)
    Ganitumab (1)
    A29L (6)
    Mirvetuximab (1)
    B6R/SL-159 (1)
    CD274/PD-L1/B7-H1 (5)
    Necitumumab (1)
    Bimekizumab (1)
    Zenocutuzumab (1)
    TRP-1 & CD3e (1)
    S100P (1)
    CD223/LAG3 & CD152/CTLA4 (1)
    S100A10 (4)
    Lintuzumab (1)
    CD274/PD-L1 & CD47/MER6 (1)
    CD274/PD-L1 & SLT-Ia (1)
    CD80/B7-1 (20)
    Oxelumab (1)
  • Especies
    0 seleccionado
    Cat (1)
    Mouse (27)
    Canis lupus familiaris (1)
    Rat (1)
    Neosartorya fumigata (1)
    Tupaia chinensis (12)
    Mus musculus (Mouse) (7)
    Canis lupus familiaris (Dog) (8)
    Homo sapiens (Human) (7)
    Dog (3)
    Human (178)
    Felis catus (Cat) (9)
  • Aplicaciones
    0 seleccionado
    SDS-PAGE (75)
    Bioactivity: FACS (1)
    Functional assay (158)
    in vitro PD-L1 blockade (3)
    FACS (5)
    Inmunógeno (75)
    Research in vivo (158)
    IHC-F (3)
    IF (8)
    Functional assay (6)
    Bioactivity testing in progress (31)
    Research in vivo (4)
    Neutralization (2)
    Blocking (2)
    in vivo CTLA-4 neutralization (2)
    ELISA (844)
    GICA (2)
    in vivo (2)
    in vivo intra-tumoral regulatory T cell depletion (2)
    in vivo blockade (2)
    Neut (1)
    FCM (152)
    IHC (84)
    FuncS (18)
    Inhib (1)
    WB (165)
    IFA (4)
    SPR (4)
    Bioactivity: FACS (153)
    in vivo PD-L1 blockade (3)
    IP (2)
  • Reactividad
    0 seleccionado
    Broad-Spectrum (1)
    Xenopus laevis (1)
    Macaca mulatta (1)
    Drosophila grimshawi (1)
    Bovine (1)
    Rat (16)
    Drosophila willistoni (1)
    Neosartorya fumigata (1)
    Homo sapiens (Human) (4)
    Monkey (5)
    Kirsten murine sarcoma virus (1)
    Cat (1)
    Kryptolebias marmoratus (1)
    Avian retrovirus IC10 (1)
    Chicken (4)
    Limanda limanda (1)
    Avian rous-associated virus type 1 (1)
    Carassius auratus (1)
    Tupaia chinensis (4)
    Pig (6)
    Mesocricetus auratus (1)
    Bos taurus (8)
    Coturnix japonica (1)
    Cavia porcellus (1)
    Mouse (78)
    Cynomolgus monkey (1)
    Dog (13)
    Human (198)
    Callithrix jacchus (1)
    Monodelphis domestica (1)
    Oryctolagus cuniculus (4)
    Pongo abelii (2)
    Cyprinus carpio (1)
    B7-H1 / PD-L1 / CD274 (1)
    Rhesus macaque (1)
    Mus musculus (Mouse) (1)
    Capra hircus (1)
    Oryzias latipes (1)
    Danio rerio (1)
  • Especie huésped
    0 seleccionado
    Chimeric (5)
    Rat (14)
    Humanized (34)
    Alpaca (6)
    HEK293T (1)
    Human (157)
    Dog (2)
    Mouse (164)
    Rabbit (61)
    Armenian Hamster (5)
  • Clonalidad
    0 seleccionado
    Polyclonal (53)
    Monoclonal (398)
  • Conjugado
    0 seleccionado
    FITC (28)
    APC (28)
    PerCP (28)
    Unconjugated (301)
    PE (28)

Acceso rápido

Contáctenos

  • +86-027-65523339

  • info@abinscience.com

  • Edificio C, No. 666, Calle Shendunsi, Wuhan, 430206, China

  • linkedin
  • Ins
  • youtube
  • youtube
Derechos de autor © 2026 abinScience. Todos los derechos reservados. Todos los productos son solo para uso de investigación